Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.43 |
| ▸ | CA2 | P00918 | 4/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | CA7 | P43166 | 2/20 | 0.43 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20415090 | 0.83 | CA1 (0.53) | CA1CA2CA12CA7CA13 | |
| SCHEMBL23964412 | 0.80 | — | — | |
| SCHEMBL20408923 | 0.76 | CA12 (0.45) | CA1CA2CA12CA7CA13 | |
| SCHEMBL20398175 | 0.72 | CA12 (0.30) | CA1CA2CA12CA7CA13 | |
| SCHEMBL20398139 | 0.72 | CA12 (0.30) | CA1CA2CA12CA7CA13 | |
| SCHEMBL12129751 | 0.71 | CA1 (0.56) | CA1CA2CA12CA7CA13 | |
| SCHEMBL20398209 | 0.70 | CA1 (0.30) | CA1CA2 | |
| SCHEMBL22485201 | 0.68 | CA12 (0.37) | CA1CA2CA12CA7CA13 | |
| SCHEMBL20415031 | 0.68 | CA12 (0.36) | CA1CA2CA12CA7CA13 | |
| SCHEMBL22485204 | 0.67 | CA12 (0.36) | CA1CA2CA12CA7CA13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11155674-B2 | Polymerizable sulfonamide compounds and polymers thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11155674-B2 | Polymerizable sulfonamide compounds and polymers thereof | STS, SELE, SCAMP2 | CA1 453/4885CA2 305/4885CA12 361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.